« Previous
Next »
Titles
- M4 organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use1
- M4E(R2): the CTD--efficacy1
- M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk1
- MAT for hospitalized patients1
- MAT for opioid use disorder: overcoming objections1
- MAT in community health centers1
- MAT in the emergency department: FAQ1
- MRI screening: what's in your pocket?1
- Making a connection: clinics collaborate on EHR deployment1
- Making drug costs more transparent to consumers: a summary for policymakers1
- Making health care costs more transparent to consumers: a summary for policymakers1
- Making health happen for our sons and brothers1
- Making patient-controlled analgesia safer for patients1
- Making quality matter in Medi-Cal managed care: how other states hold health plans financially accountable for performance1
- Making the case for prevention: why Washington's Accountable Communities of Health should pursue Domain 3D chronic disease prevention projects1
- Making the connection with HIT1
- Making use of all-payer claims databases for health care reform evaluation1
- Malignant hyperthermia: is your facility prepared to treat this rare condition?1
- Managed care1
- Managed care in California: cost concerns influence product design1